2 unchanged sentences
None of our directors or Section 16 officers informed
−Removed: us of the adoption , modification or termination of a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading
−Removed: arrangement” (in each case, as defined in Item 408(a) of Regulation S-K) during the three-month period ended June 30, 2026.
+Added: us of the adoption , modification or termination of a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement”
+Added: (in each case, as defined in Item 408(a) of Regulation S-K) during the three-month period ended March 31, 2026.
Articles of Incorporation, as amended (incorporated by reference to Exhibit 3.1 to our Annual Report on Form 10-K for the year ended September 30, 2021 filed on November 24, 2021)
Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 to our Current Report on Form 8-K filed on April 14, 2023)
−Removed: Employment Agreement, dated May 4, 2026, by and between Anavex Life Sciences Corp.
−Removed: and Terrie Kellmeyer, Ph.D .
−Removed: Certification of Terrie Kellmeyer, Ph.D.
+Added: Certification of Terrie Kellmeyer, PhD.
Certification of Sandra Boenisch
8 unchanged sentences
** Furnished herewith.
−Removed: Indicates management contract or compensatory plan.
Pursuant to the requirements of the Securities Exchange
1 unchanged sentence
ANAVEX LIFE SCIENCES CORP.
−Removed: /s/Terrie Kellmeyer, Ph.D.
−Removed: Terrie Kellmeyer, Ph.D.
+Added: /s/Terrie Kellmeyer, PhD
+Added: Terrie Kellmeyer, PhD
Interim Chief Executive Officer
7 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.